On January 16, the U.S. Food and Drug Administration (FDA) announced that it is revoking the authorization for use of FD&C Red No. 3 in ...
Rising diagnoses of certain cancers in people under 50 predate the rollout of COVID-19 vaccines by decades, undermining ...
Therapy will cost Rs 35 to 50 lakh. India sees around 1.20 lakh new blood cancer cases and over 70,000 deaths annually from ...
In the CodeBreaK 300 trial, sotorasib and panitumumab had better response rates and improved PFS vs standard-of-care ...
Daiichi Sankyo shares rose sharply after the U.S. Food and Drug Administration approved its breast cancer drug Datroway. Shares were recently 8.7% higher at 4,437 yen, equivalent to $28.39, on Monday ...
On Wednesday, the Food and Drug Administration revoked authorization for the use of red dye No. 3 in food and ingested drugs.
A drug from AstraZeneca and Daiichi Sankyo won authorization for a form of breast cancer, the first U.S. approval for the ...
While it caused cancer in these male rats, the dye does not cause cancer in humans and other animals in the same way, ...
The colorant was banned from cosmetics and non-oral medications years ago because a study showed it caused cancer in rats.
The Trump administration has promised an overhaul of various government agencies. What will happen to the Health Department?
Following the U.S. Food and Drug Administration's (FDA) order banning the use of Red Dye No. 3 in food products, Illinois ...
The decision came after years of scrutiny and debate over the safety of Red No. 3, particularly concerning its potential ...